Journal Article Summary
The article investigates how body weight affects the pharmacokinetics of levonorgestrel, a common emergency contraceptive, in women with varying body mass indexes (BMIs). Understanding this relationship is important because previous studies have suggested that the effectiveness of emergency contraception may decrease in women who are obese or extremely obese. By examining how the drug is absorbed, distributed, and metabolized in these different populations, the study aims to clarify potential disparities in contraceptive efficacy based on body weight.
The researchers conducted a study involving healthy women aged 18 to 35 with normal, obese, and extremely obese BMIs. They administered a single 1.5 mg dose of levonorgestrel and measured its concentration in the blood over 96 hours. The findings revealed that women with normal BMI had higher levels of the drug in their system compared to those who were obese or extremely obese, indicating that body weight may influence how well the drug is absorbed and utilized by the body. Specifically, the total and bioavailable concentrations of levonorgestrel were significantly lower in the obese groups, which may contribute to reduced effectiveness in these populations.
Despite the insights gained, the study has limitations, including the reliance on calculated values for free levonorgestrel rather than direct measurements. Additionally, the assumption that the drug's bioavailability is consistent across different body types may not hold true. Patients should discuss these findings with their healthcare providers, particularly if they are considering using levonorgestrel as an emergency contraceptive, to ensure they understand how their body weight may impact the drug's effectiveness and explore alternative options if necessary.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Natavio Melissa, Stanczyk Frank Z, Molins Emilie A G, Nelson Anita, Jusko William J. Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index. Contraception 2019. DOI: 10.1016/j.contraception.2019.01.003. PMID: 30703352. PMCID: PMC6499670.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
